Cite
HARVARD Citation
O'Riordan, W. et al. (n.d.). Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens. Open forum infectious diseases. p. S532. [Online].